Nasdaq 100 Stocks SEC Filings — May 05, 2026

05-05-2026

Canadian Derivatives Clearing Corporation (CDCC) filed an 8-K on May 5, 2026, reporting under Item 9.01 with Exhibit 99.1, providing an updated list of underlying interests for options listed on the Montreal Exchange and offered for sale in the United States pursuant to its Form S-20 registration statement as of April 30, 2026. The exhibit details equity options on over 150 Canadian companies and trusts (e.g., 5N Plus Inc. (VNP), Bank of Montreal (BMO), Shopify Inc. (SHOP)); index options on S&P/TSX 60 (SXO), Capped Utilities (SXV), and Banks (SXJ); options on closed-end funds (CEFs) like Sprott Physical Gold Trust (PHYS); Canadian Depositary Receipts (CDRs) for U.S. equities such as Nvidia (NVDA), Tesla (TSLA); and options on numerous ETFs including BMO S&P/TSX Capped Composite Index ETF (ZCN) and CI Galaxy Bitcoin ETF (BTCX). No financial performance metrics, changes, or comparisons are reported.

05-05-2026

PayPal reported Q1 2026 net revenues of $8.4 billion, up 7% YoY (5% FXN), with TPV increasing 11% to $464.0 billion and transaction margin dollars up 3% to $3.8 billion. However, GAAP operating income fell 3% to $1.5 billion with operating margin contracting 182 basis points to 17.8%, non-GAAP operating margin down 229 bps to 18.4%, and GAAP EPS declining 6% to $1.21, though non-GAAP EPS edged up 1% to $1.34. Active accounts grew 1% to 439 million but declined sequentially by 0.2 million, while the company repurchased $1.5 billion in shares and declared a $0.14 per share dividend.

• ·Cash flow from operations: $1.1 billion; free cash flow: $0.9 billion; adjusted free cash flow: $1.7 billion (up 25% YoY).
• ·Dividend: $0.14 per share, payable June 25, 2026, to stockholders of record June 4, 2026.
• ·FY'26 guidance reiterated: non-GAAP EPS low-single digit decline to slightly positive (prior year $5.31).
• ·Q2'26 non-GAAP EPS guidance: high-single digit decline or approximately (-9%) (prior year $1.40).
• ·Total assets: $80,546 million as of March 31, 2026.

05-05-2026

Amalgamated Financial Corp. reported Q1 2026 net income of $25,223 thousand (up 0.8% YoY from $25,028 thousand), with net interest income growing 13.5% YoY to $80,156 thousand on higher loan ($63,471 thousand) and securities ($44,189 thousand) income. However, provision for credit losses surged to $13,488 thousand from $596 thousand, causing net interest income after provision to decline 4.7% YoY to $66,668 thousand, while non-interest expense rose 10.2% to $45,888 thousand. Total assets expanded 3.4% QoQ to $9,170,892 thousand, driven by 1.3% QoQ growth in net loans receivable to $4,965,203 thousand and 2.9% QoQ increase in deposits to $8,178,084 thousand.

• ·Earnings per common share - basic: $0.85 (Q1 2026) vs $0.82 (Q1 2025)
• ·Dividends declared: $0.17 per share (Q1 2026) vs $0.14 per share (Q1 2025)
• ·Net cash used in investing activities: $387,352 thousand (Q1 2026) vs $6,611 thousand (Q1 2025)
• ·Accumulated other comprehensive loss increased to $(36,586) thousand from $(32,088) thousand QoQ

05-05-2026

Varma Mutual Pension Insurance Co reported 13F-HR holdings as of March 31, 2026, totaling $16977469973 across 319 positions, all with sole voting power and no reported changes or shared discretion. Top holdings by value include NVIDIA Corporation (681601590), Apple Inc. (618456537), Alphabet Inc. Cap Stk Cl A (443474744), Microsoft Corp (413878193), and Amazon Com Inc (324299508). The portfolio features heavy exposure to U.S. technology stocks and ETFs, with no period-over-period comparisons provided in the filing.

• ·Filing date: May 05, 2026
• ·Report period end: March 31, 2026
• ·All positions reported with sole voting power (SH SOLE) and zero shared or other discretion

05-05-2026

Metallus Inc. reported Q1 2026 net sales of $308.3M, up 9.9% YoY from $280.5M, driven by strong growth in Aerospace & Defense (+59.7%) and Industrial (+10.4%), with gross profit rising 14.6% to $25.1M and net income surging to $5.4M from $1.3M. However, Automotive sales were nearly flat (-0.4%) and Energy declined 7.0% YoY, while cash from operations remained negative at -$26.9M (improved from -$38.9M) leading to cash dropping to $104.0M from $156.7M at year-end.

• ·Cash used in operating activities improved to -$26.9M from -$38.9M YoY.
• ·Capital expenditures of $24.7M in Q1 2026, down from $27.5M in Q1 2025.
• ·Government funding proceeds of $5.9M in Q1 2026, down from $12.9M in Q1 2025.
• ·Comprehensive income of $0.7M in Q1 2026, up slightly from $0.4M in Q1 2025.

05-05-2026

Pineapple Express Cannabis Company dismissed Aloba Awomolo & Partners (PCAOB ID 7275) as its independent registered public accounting firm on April 25, 2026, approved by the Board of Directors, with the prior audit report for FY ended January 31, 2025 noting substantial doubt about going concern but no disagreements or reportable events. The Company engaged Boladale Lawal & Co. (PCAOB ID 6993) as its new independent auditor on April 30, 2026, for the fiscal year ending January 31, 2026, with no prior consultations. The Company lacks a separate audit committee, with functions performed by the full Board.

• ·Aloba to provide letter to SEC on Form 8-K disclosures, to be filed as Exhibit 16.1 in amendment.
• ·Company CIK: 0001710495; EIN: 33-3266062; Commission File Number: 001-41762; Fiscal year end: January 31.
• ·No securities registered pursuant to Section 12(b) of the Act; not an emerging growth company.

05-05-2026

The Federal Home Loan Bank of San Francisco disclosed under Item 2.03 the creation of direct financial obligations consisting of two new consolidated obligation bonds for which it is the primary obligor, each with a par value of $250,000,000. The first bond (CUSIP 3130BAKD8), traded on April 29, 2026, carries a 3.800% fixed constant rate, matures on January 29, 2027, and has an optional principal redemption call on October 29, 2026. The second bond (CUSIP 3130BAMC8), traded on May 1, 2026, carries a 3.820% fixed constant rate, matures on February 4, 2027, with a call on November 4, 2026.

• ·Consolidated obligations are joint and several obligations of the eleven Federal Home Loan Banks, backed only by their financial resources, not guaranteed by the U.S. government.
• ·Both bonds have Optional Principal Redemption call type (European style).
• ·Schedule A excludes discount notes with maturity of one year or less issued in ordinary course.

05-05-2026

Entravision reported Q1 2026 consolidated net revenue of $196.971 million, up 114% YoY from $91.851 million, driven by 204% growth in the Advertising Technology & Services (ATS) segment to $154.550 million, while Media segment revenue grew modestly 4% to $42.421 million with local advertising up 6% but national advertising down 18% excluding political. Segment operating profit rose to $29.088 million from $3.894 million, boosted by ATS profit of $34.306 million (up 427%), however Media operating loss widened to $5.218 million from $2.614 million. Net income was $12.360 million ($0.13/share) vs loss of $47.966 million (-$0.53/share), with $5 million debt repayment, $71.1 million cash/marketables, and $162.2 million debt.

• ·Dividend declared $0.05 per share payable June 30, 2026 to shareholders of record June 16, 2026.
• ·Capital expenditures $3.897 million in Q1 2026 vs $2.384 million Q1 2025.
• ·Cash flow from operations $21.784 million in Q1 2026 vs -$15.244 million Q1 2025.
• ·Current maturities of long-term debt $20 million as of March 31, 2026.

05-05-2026

Community Healthcare Trust (CHCT) reported Q1 2026 net income of $2.5 million ($0.07 per diluted share), up from $1.6 million ($0.03 per share) YoY, with FFO at $0.49 per share (up from $0.47) and AFFO at $0.56 per share (up from $0.55); rental income rose 5% YoY to $31.3 million. The company acquired a $28.5 million inpatient rehab facility (9.3% expected return) and sold a property for $5.2 million net proceeds, but stockholders' equity declined to $421 million from $429 million QoQ amid rising debt to $559 million. A geriatric behavioral tenant paid $0.3 million rent (up slightly QoQ) but faces sale uncertainty, while four pipeline properties total $99 million at 9.1-9.75% returns.

• ·Geriatric behavioral hospital tenant (six properties) paid $0.3 million rent in Q1 2026, up $0.1 million from Q4 2025; LOI signed July 2025 for business sale, progressing to definitive documents.
• ·No shares issued under ATM program in Q1 2026.
• ·Dividend payable May 22, 2026 to stockholders of record May 11, 2026.
• ·Properties located in 36 states.

05-05-2026

AMD reported Q1 2026 revenue of $10.3 billion, up 38% YoY but flat QoQ, driven by Data Center segment growth to $5.8 billion (+57% YoY) while Client & Gaming reached $3.6 billion (+23% YoY) and Embedded was $873 million (+6% YoY). Non-GAAP operating income was $2.5 billion (+43% YoY) but down 11% QoQ, with gross margin at 55% (up 1 ppt YoY, down 2 ppts QoQ). Q2 outlook projects revenue of approximately $11.2 billion (+46% YoY, +9% QoQ) with non-GAAP gross margin around 56%.

• ·Gaming revenue growth of 11% YoY partially offset by lower semi-custom revenue.
• ·Q2 revenue guidance: $11.2 billion +/- $300 million.
• ·Meta plans first 1-GW deployment powered by custom AMD Instinct MI450-based GPU.
• ·Non-GAAP gross margin expected at 56% for Q2.

05-05-2026

Apple Hospitality REIT, Inc. (APLE) filed an 8-K on May 5, 2026, announcing the availability of an updated investor presentation on its website, which includes certain operating statistics for April 2026. The presentation is furnished as Exhibit 99.1 for use at upcoming conferences and meetings. No specific financial metrics or period-over-period comparisons are detailed in the filing.

• ·Filing includes Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
• ·Presentation not deemed 'filed' under Section 18 of the Exchange Act

05-05-2026

Amazon.com Inc filed its 13F-HR on May 5, 2026, for the quarter ended March 31, 2026, disclosing sole holdings in five public companies with no reported changes or performance metrics provided. The largest position is in Rivian Automotive Inc Class A, valued at $2383375702 with 158363834 shares. Other holdings include Beta Technologies Inc ($172782271, 11753896 shares), Marvell Technology Inc ($39258666, 396352 shares), Astera Labs Inc ($30444359, 277777 shares), and Nautilus Biotechnology Inc ($5653373, 1457055 shares).

• ·SEC file number: 028-20693
• ·Central Index Key: 0001018724
• ·Fiscal year end: December 31
• ·All holdings reported as SOLE with no other voting authority or put/call options

05-05-2026

Mueller Water Products reported fiscal 2026 Q2 net sales of $384.4 million, up 5.5% YoY from $364.3 million, with adjusted EBITDA increasing 15.0% to $97.2 million and adjusted operating margin expanding 200 basis points to 22.1%. The company raised FY2026 adjusted EBITDA guidance to $360-365 million but noted declines in six-month net cash from operating activities to $48.4 million from $68.4 million and free cash flow to $16.5 million from $47.3 million. Water Management Solutions sales grew 12.2% to $166.1 million, while Water Flow Solutions rose only 1.0% to $218.3 million.

• ·Raised FY2026 adjusted EBITDA guidance to $360-365 million (10.4%-11.9% YoY growth).
• ·Total liquidity of $584.7 million as of March 31, 2026.
• ·FY2026 guidance: net sales $1,470-1,490 million; capex $60-65 million; effective tax rate 24-25%.
• ·Incured $4.4 million in strategic reorganization and other charges in Q2.

05-05-2026

INmune Bio Inc. (NASDAQ: INMB) and Anthony Nolan announced an amended and restated Material Transfer and License Agreement, effective April 29, 2026, expanding their CORDStrom™ MSC platform collaboration to secure long-term umbilical cord tissue supply for therapies targeting RDEB, oncology (CORDStrom-TRAIL), and inflammatory diseases like osteoarthritis and SLE. The partnership leverages Anthony Nolan's expertise to ensure MSC consistency, regulatory compliance (FDA, EMA, MHRA), and scalable off-the-shelf treatments. No financial terms were disclosed, and there are no reported declines or challenges in the announcement.

• ·Initial Indications: Recessive Dystrophic Epidermolysis Bullosa (RDEB), CORDStrom-col7a for EB, solid tumors (oncology), Osteoarthritis, Systemic Lupus Erythematosus (SLE)
• ·Agreement includes GMP and HTA standards for traceability and quality
• ·Anthony Nolan helps four people per day with transplants

05-05-2026

Sharpepoint LLC filed its 13F-HR report disclosing 86 equity holdings with a total market value of $167708548 thousand (167.7B USD) as of March 31, 2026. The portfolio is heavily weighted toward ETFs including iShares 20+ Year Treasury Bond ETF ($8696318 thousand, largest position) and PIMCO Multisector Bond ETF ($6329683 thousand), alongside individual stocks like Eli Lilly & Co ($7235155 thousand) and NVIDIA ($5567571 thousand). No period-over-period changes are disclosed in this filing.

• ·Filing date: May 05, 2026
• ·Report period end: March 31, 2026
• ·All positions held with sole investment discretion
• ·State of incorporation: AZ
• ·Business address: 5090 N 40th St Suite 200, Phoenix, AZ 85018

05-05-2026

On May 5, 2026, The Farmers Bancorp made available a reminder letter to its shareholders (Exhibit 99.1) regarding the pending merger with Richmond Mutual Bancorporation, Inc. The joint proxy statement/prospectus in RMBI's Form S-4 registration statement was declared effective by the SEC on April 3, 2026. The filing highlights forward-looking statements and various risks, including potential termination, regulatory approval failures, integration challenges, and economic uncertainties, with no specific financial metrics updated.

• ·Form S-4 registration statement includes joint proxy statement/prospectus, available at www.sec.gov.
• ·Shareholders of Farmers urged to read proxy materials; requests to The Farmers Bancorp at 9 East Clinton Street, Frankfort, Indiana 46041.
• ·Filing satisfies Rule 425 and Rule 14a-12 obligations.

05-05-2026

On May 1, 2026, Timothy Terry retired as principal executive officer of OptimumBank Holdings, Inc. and as President and Chief Executive Officer of its subsidiary OptimumBank, with assistance in the leadership transition. Effective the same date, Chairman Moishe Gubin was appointed Chief Executive Officer and principal executive officer of the Company and CEO of the Bank, while Braden R. Smith was appointed President of the Bank. This represents a smooth internal and external leadership change with no disclosed performance issues.

• ·Braden R. Smith served as Chief Business Development Officer of Amerant Bank from November 2024 through April 2026, and as Executive Vice President of Wintrust Financial Corporation from September 2009 to November 2024.
• ·Filing dated May 5, 2026, reporting events of May 1, 2026.

05-05-2026

Factory Mutual Insurance Co filed its 13F-HR on May 05, 2026, disclosing 196 equity and ETF positions held solely as of March 31, 2026, with no reported changes or shared voting authority. Top holdings by value include NVIDIA Corporation at $506204371, Apple Inc at $431638672, Alphabet Inc CAP STK CL C at $430152594, and Microsoft Corp at $360015497. The portfolio emphasizes technology sector leaders and diversified ETFs such as J P MORGAN EXCHANGE TRADED F CORE PLUS BD ETF at $275244463.

• ·Filing period end date: 2026-03-31
• ·Filed as of date: 2026-05-05
• ·All positions reported as SOLE with no put/call activity or other managers

05-05-2026

Illinois Municipal Retirement Fund filed its 13F-HR on May 5, 2026, disclosing 1,127 equity positions held with sole voting power as of March 31, 2026, with a total market value of $7,859,285,301. Largest holdings include Apple Inc. ($293,119,329; 1,154,968 shares), Alphabet Inc. Class A ($170,563,051; 593,139 shares), and Amazon.com Inc. ($149,029,889; 715,561 shares). No changes or performance metrics were reported in this snapshot filing.

• ·Filing submitted from Oak Brook, IL; contact phone 630-368-5380.
• ·All 1,127 positions held with sole voting power (SH SOLE); no shared power, puts, or calls reported.
• ·SEC file number: 028-19769.

05-05-2026

SBA Communications reported Q1 2026 total revenues of $703.4M, up 5.9% YoY from $664.2M, driven by 6.5% growth in site leasing to $656.1M, though site development revenues declined 1.6% to $47.3M. Operating income rose 2.4% YoY to $342.8M; however, net income attributable to SBA fell 16.2% to $184.8M due to higher interest expense of $128.5M (up 23.4% YoY). Cash provided by operating activities decreased 15.4% to $255.1M, while total assets grew slightly to $11.7B.

• ·Interest expense increased to $128,529 from $104,148 YoY.
• ·Dividends and dividend equivalents on common stock: $133,536 in Q1 2026.
• ·Acquisitions cash outflow: $143,496 in Q1 2026.
• ·Net cash used in investing activities: $296,771 in Q1 2026 (vs provided $238,266 in Q1 2025).
• ·Total cash, cash equivalents, and restricted cash at end of Q1 2026: $332,512 (down from $437,021 at Dec 31, 2025).

05-05-2026

For Q1 2026, Weave Communications reported revenue of $65,500, up 17% YoY from $55,809, with gross profit rising 19% to $47,539; operating loss narrowed to $6,023 from $9,320, and net loss improved to $5,770 from $8,825. However, total operating expenses increased 9% YoY to $53,562, net cash used in operating activities deteriorated to $5,705 from $219, and cash and equivalents declined 23% QoQ to $42,214 from $54,959.

• ·Stock-based compensation expense Q1 2026: $7,157
• ·Intangible assets net Mar 31 2026: $6,793 (down QoQ from $7,134)
• ·Goodwill stable at $29,465
• ·Acquisition purchase consideration: $35,915 (prior, with $29,465 goodwill)

05-05-2026

Mustang Bio reported a net loss of $955 for Q1 2026, significantly wider than the $153 loss in Q1 2025, primarily due to total operating expenses rising to $1,058 from $253 amid a shift in R&D from a $964 credit to $178 expense, though G&A expenses declined to $880 from $1,217. Cash and cash equivalents fell to $16,258 from $17,266 at December 31, 2025, reflecting $1,008 used in operations (improved from $1,389 YoY), with no financing inflows this quarter versus $7,616 in Q1 2025. Stockholders’ equity decreased to $8,596 from $9,529 QoQ.

• ·Research and development expenses $178 in Q1 2026 vs $(964) credit in Q1 2025
• ·No cash flows from financing activities in Q1 2026 vs $7,616 provided in Q1 2025
• ·Accounts payable and accrued expenses $5,315 as of March 31, 2026 (includes $3,341 accounts payable, $273 accrued R&D, $160 accrued compensation)